ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

November 22, 2006

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy

September 10, 1982

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991